IM, S., ML, H., MZ, L., MP, S., I, G., N, L., . . . JA, F. (2022). Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST. British journal of cancer, 127(11), 2072. https://doi.org/10.1038/s41416-022-01990-5
Chicago Style (17th ed.) CitationIM, Schaefer, et al. "Concurrent Inhibition of CDK2 Adds to the Anti-tumour Activity of CDK4/6 Inhibition in GIST." British Journal of Cancer 127, no. 11 (2022): 2072. https://doi.org/10.1038/s41416-022-01990-5.
MLA (9th ed.) CitationIM, Schaefer, et al. "Concurrent Inhibition of CDK2 Adds to the Anti-tumour Activity of CDK4/6 Inhibition in GIST." British Journal of Cancer, vol. 127, no. 11, 2022, p. 2072, https://doi.org/10.1038/s41416-022-01990-5.
Warning: These citations may not always be 100% accurate.